Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile
TG Therapeutics - Stock

TG Therapeutics Stock

TGTX
US88322Q1085
A1JXW7

Price

18.15
Today +/-
+0
Today %
+0 %
P

TG Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into TG Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by TG Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects TG Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of TG Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into TG Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing TG Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on TG Therapeutics’s growth potential.

TG Therapeutics Revenue, EBIT and net profit per share

DateTG Therapeutics RevenueTG Therapeutics EBITTG Therapeutics Net Income
2029e1.5 B undefined0 undefined709.34 M undefined
2028e1.32 B undefined675.65 M undefined604.51 M undefined
2027e1.04 B undefined477.05 M undefined399.59 M undefined
2026e699.34 M undefined200.74 M undefined218.32 M undefined
2025e481.82 M undefined106.43 M undefined92.41 M undefined
2024e314.9 M undefined-6.53 M undefined-2.96 M undefined
2023233.66 M undefined20.63 M undefined12.67 M undefined
20222.79 M undefined-192.84 M undefined-198.34 M undefined
20216.69 M undefined-344.77 M undefined-348.1 M undefined
2020150,000 undefined-273.59 M undefined-279.38 M undefined
2019150,000 undefined-169.06 M undefined-172.87 M undefined
2018150,000 undefined-174.4 M undefined-173.48 M undefined
2017150,000 undefined-118.71 M undefined-118.48 M undefined
2016150,000 undefined-78.97 M undefined-78.25 M undefined
2015150,000 undefined-63.18 M undefined-62.95 M undefined
2014150,000 undefined-55.72 M undefined-55.78 M undefined
2013150,000 undefined-20.17 M undefined-20.48 M undefined
201220,000 undefined-25.8 M undefined-18.07 M undefined
20110 undefined-880,000 undefined-850,000 undefined
20100 undefined-2.02 M undefined620,000 undefined
20090 undefined-1.77 M undefined-2.79 M undefined
20080 undefined-4.41 M undefined-4.27 M undefined
20070 undefined-12.14 M undefined-12.03 M undefined
20060 undefined-10 M undefined-9.69 M undefined
20050 undefined-7.47 M undefined-19.32 M undefined
20040 undefined-6.14 M undefined-6.48 M undefined

TG Therapeutics Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
00000000000000000000.0100.230.310.480.71.041.321.5
---------------------66.6711,550.0034.7653.1845.3248.9326.8013.64
-------------------83.33100.0093.99------
000000000000000000052219000000
-1-3-6-7-10-12-4-1-20-25-20-55-63-78-118-174-169-273-344-19220-61062004776750
--------------------5,733.33-9,600.008.58-1.9122.0428.6145.8251.14-
-1-6-6-19-9-12-4-200-18-20-55-62-78-118-173-172-279-348-19812-292218399604709
-500.00-216.67-52.6333.33-66.67-50.00---11.11175.0012.7325.8151.2846.61-0.5862.2124.73-43.10-106.06-116.67-4,700.00136.9683.0351.3817.38
00.010.010.020.020.020.030.030.042.1713.1125.4134.0745.6549.0462.0775.4788.37115.33132.22135.41148.51000000
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

Revenue and Growth

The TG Therapeutics Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the TG Therapeutics is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of TG Therapeutics provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand TG Therapeutics's financial health and stability.

Assets

TG Therapeutics's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that TG Therapeutics must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of TG Therapeutics after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into TG Therapeutics's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-1-5-5-19-9-12-4-200-26-20-55-62-78-118-173-172-279-348-19812
0000000000000000000000
0000000000000000000000
000100000004-52882725-19-12-1-84
020111112-2023104731153229251641254278
0000000000000000004358
0000000000000000000000
0-3-5-6-7-10-4-1-10-5-10-35-44-61-93-128-132-214-295-176-31
0000000000000000000000
00-430000000-4-18-2426-810-240-20-50
00-431000000-4-18-2426-810-240-20-50
0000000000000000000000
0000001000000000029040025
193120700291239696851331131756792047
2831107301911396868513311320467941072
0000002000000000000-100
0000000000000000000000
15-68-6-20009624150-3031-1470440-254-196-9
-0.77-3.46-5.83-6.29-7.79-10.24-4.45-1.05-1.97-0.09-5.19-10.75-35.08-44.73-61.93-93.76-129.02-132.94-214.87-296.03-176.18-31.41
0000000000000000000000

TG Therapeutics stock margins

The TG Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of TG Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for TG Therapeutics.
  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the TG Therapeutics's sales revenue. A higher gross margin percentage indicates that the TG Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the TG Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the TG Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the TG Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the TG Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the TG Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

TG Therapeutics Margin History

TG Therapeutics Gross marginTG Therapeutics Profit marginTG Therapeutics EBIT marginTG Therapeutics Profit margin
2029e93.95 %0 %47.26 %
2028e93.95 %51.19 %45.8 %
2027e93.95 %45.83 %38.39 %
2026e93.95 %28.7 %31.22 %
2025e93.95 %22.09 %19.18 %
2024e93.95 %-2.07 %-0.94 %
202393.95 %8.83 %5.42 %
202290.32 %-6,911.83 %-7,108.96 %
202188.19 %-5,153.51 %-5,203.29 %
202093.95 %-182,393.32 %-186,253.33 %
201993.95 %-112,706.67 %-115,246.66 %
201893.95 %-116,266.66 %-115,653.32 %
201793.95 %-79,140 %-78,986.66 %
201693.95 %-52,646.67 %-52,166.66 %
201593.95 %-42,120 %-41,966.67 %
201493.95 %-37,146.67 %-37,186.66 %
201393.95 %-13,446.67 %-13,653.33 %
201293.95 %-129,000 %-90,350 %
201193.95 %0 %0 %
201093.95 %0 %0 %
200993.95 %0 %0 %
200893.95 %0 %0 %
200793.95 %0 %0 %
200693.95 %0 %0 %
200593.95 %0 %0 %
200493.95 %0 %0 %

TG Therapeutics Stock Sales Revenue, EBIT, Earnings per Share

The TG Therapeutics earnings per share therefore indicates how much revenue TG Therapeutics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue TG Therapeutics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates TG Therapeutics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of TG Therapeutics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating TG Therapeutics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

TG Therapeutics Revenue, EBIT and net profit per share

DateTG Therapeutics Sales per ShareTG Therapeutics EBIT per shareTG Therapeutics Earnings per Share
2029e9.71 undefined0 undefined4.59 undefined
2028e8.54 undefined0 undefined3.91 undefined
2027e6.74 undefined0 undefined2.59 undefined
2026e4.53 undefined0 undefined1.41 undefined
2025e3.12 undefined0 undefined0.6 undefined
2024e2.04 undefined0 undefined-0.02 undefined
20231.57 undefined0.14 undefined0.09 undefined
20220.02 undefined-1.42 undefined-1.46 undefined
20210.05 undefined-2.61 undefined-2.63 undefined
20200 undefined-2.37 undefined-2.42 undefined
20190 undefined-1.91 undefined-1.96 undefined
20180 undefined-2.31 undefined-2.3 undefined
20170 undefined-1.91 undefined-1.91 undefined
20160 undefined-1.61 undefined-1.6 undefined
20150 undefined-1.38 undefined-1.38 undefined
20140 undefined-1.64 undefined-1.64 undefined
20130.01 undefined-0.79 undefined-0.81 undefined
20120 undefined-1.97 undefined-1.38 undefined
20110 undefined-0.41 undefined-0.39 undefined
20100 undefined-50.5 undefined15.5 undefined
20090 undefined-59 undefined-93 undefined
20080 undefined-147 undefined-142.33 undefined
20070 undefined-607 undefined-601.5 undefined
20060 undefined-500 undefined-484.5 undefined
20050 undefined-373.5 undefined-966 undefined
20040 undefined-614 undefined-648 undefined

TG Therapeutics business model

TG Therapeutics Inc is a biopharmaceutical company based in New York City, USA. The company was founded in 2012 and focuses on the development and commercialization of innovative therapy options for various types of cancer and autoimmune diseases. TG Therapeutics was founded as a result of a collaboration between Michael S. Weiss, an experienced investment banker and biotechnology manager, and Laurence N. Charous, an oncologist and clinical researcher. The company has roots in two predecessor companies: Manhattan Pharmaceuticals and LFB Biotechnologies. Both had failed, and TG rose from their remains. TG Therapeutics' business model is to develop a new therapy option by combining drugs of different drug classes that target the needs of patients with specific cancer conditions. The dual blockade approach, which simultaneously inhibits various signaling pathways that sustain tumor cells, is particularly promising. TG Therapeutics operates a diversified portfolio strategy and has several drug candidates in different stages of development for numerous cancer conditions, including diffuse large B-cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma, as well as autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. TG Therapeutics' main products for cancer treatments currently are umapalisib and umbralisib, both of which are PI3K delta inhibitors and are being developed for the treatment of non-Hodgkin lymphomas and chronic lymphocytic leukemia. TG-1101 (Ublituximab) is a CD20-targeted antibody therapy used in lymphomas and autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. TG Therapeutics' research and development efforts are driven by an experienced team of oncologists and scientists, including CEO Michael S. Weiss. The company maintains close relationships with academic institutions and research facilities. TG Therapeutics holds a broad patent portfolio covering technologies and compounds that can be used in cancer and autoimmune disease treatment. In 2020, TG Therapeutics' revenue reached approximately $109 million, compared to $14 million in the previous year. This increase in revenue was due to the sales of umbralisib. However, the company has not yet received FDA approval for any of its drugs in the US. TG Therapeutics expects that the future success of the company will be based on the clinical activity of its pipeline, market acceptance of its products, and successful completion of studies and regulatory approvals. As of December 31, 2020, TG Therapeutics had 248 employees. The company's leading body, the board of directors, consists of an experienced team of executives and advisors, including Chairman and CEO Michael S. Weiss, CFO Sean A. Power, CMO Adam D. Feuerstein, and COO Scott T. Smith. TG Therapeutics has had a tumultuous past, but the company can now look forward to a promising pipeline and a very strong financial position. The research and development of this biopharmaceutical company are promising, and it remains to be seen which of the research products will actually break through and be introduced to the market. TG Therapeutics is one of the most popular companies on Eulerpool.com.

TG Therapeutics SWOT Analysis

Strengths

1. Strong Pipeline: TG Therapeutics Inc maintains a robust pipeline of potential therapeutics, demonstrating their dedication to research and development.

2. Innovative Approach: The company adopts innovative approaches to develop novel therapies, contributing to their competitive advantage in the pharmaceutical industry.

3. Experienced Team: TG Therapeutics Inc is supported by a highly skilled and experienced management team, allowing for effective decision-making and strategic planning.

Weaknesses

1. Dependence on Key Products: The company's success heavily relies on the performance of a few key products in their portfolio. Any setbacks or regulatory issues concerning these products could negatively impact their financial stability.

2. Limited Market Presence: TG Therapeutics Inc may face challenges in establishing a strong market presence, as they operate in a highly competitive industry dominated by larger pharmaceutical companies.

3. Financial Constraints: The company's financial resources may limit their ability to fully explore and develop certain research opportunities, potentially hindering their growth and innovation.

Opportunities

1. Growing Demand for Innovative Therapies: The increasing demand for groundbreaking therapies presents TG Therapeutics Inc with an opportunity to capitalize on their innovative drug candidates and gain a significant market share.

2. Strategic Partnerships: Collaborating with established pharmaceutical companies or research institutions can provide TG Therapeutics Inc with additional resources, expertise, and opportunities for expansion.

3. Mergers and Acquisitions: The company could explore potential mergers or acquisitions to enhance their product portfolio, accelerate development timelines, or access new markets.

Threats

1. Stringent Regulatory Environment: The pharmaceutical industry is subject to strict regulations, which may delay or impede TG Therapeutics Inc's product development process, leading to increased costs and potential market entry barriers.

2. Patent Expirations: The expiration of key patents for competitor products may increase market competition and affect the pricing and demand for TG Therapeutics Inc's offerings.

3. Clinical Trial Risks: The company faces the inherent risks associated with clinical trials, such as unexpected adverse events or failure to demonstrate efficacy, which could negatively impact their reputation and financial performance.

TG Therapeutics valuation based on historical P/E ratio, EBIT, and P/S ratio.

TG Therapeutics shares outstanding

The number of shares was TG Therapeutics in 2023 — This indicates how many shares 148.508 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue TG Therapeutics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates TG Therapeutics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of TG Therapeutics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating TG Therapeutics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

TG Therapeutics Stock splits

In TG Therapeutics's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for TG Therapeutics.

TG Therapeutics Earnings Surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/2024-0.04 -0.07  (-92.31 %)2024 Q1
12/31/2023-0.11 -0.1  (6.02 %)2023 Q4
9/30/20230.12 0.73  (518.64 %)2023 Q3
6/30/2023-0.25 -0.34  (-34.02 %)2023 Q2
3/31/2023-0.37 -0.28  (25.23 %)2023 Q1
12/31/2022-0.27 -0.39  (-47.06 %)2022 Q4
9/30/2022-0.35 -0.26  (25.35 %)2022 Q3
6/30/2022-0.52 -0.3  (42.33 %)2022 Q2
3/31/2022-0.61 -0.51  (15.87 %)2022 Q1
12/31/2021-0.65 -0.7  (-8.44 %)2021 Q4
1
2
3
4
5
...
6

Eulerpool ESG Scorecard© for the TG Therapeutics stock

Eulerpool World ESG Rating (EESG©)

59/ 100

🌱 Environment

62

👫 Social

73

🏛️ Governance

42

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

Kontaktformular an uns. The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

TG Therapeutics Stock Shareholders

%
Name
Stocks
Change
Date
8.83 % The Vanguard Group, Inc.13,642,307199,77012/31/2023
8.14 % Weiss (Michael S)12,574,9291,001,9081/6/2024
5.97 % BlackRock Institutional Trust Company, N.A.9,219,990728,59612/31/2023
5.34 % State Street Global Advisors (US)8,253,573-1,564,04912/31/2023
2.62 % Darwin Global Management Ltd4,046,5984,046,59812/31/2023
2.19 % Pictet Asset Management Ltd.3,385,2452,564,84212/31/2023
2.03 % Wellington Management Company, LLP3,139,76443,29012/31/2023
2.00 % Geode Capital Management, L.L.C.3,096,646162,82012/31/2023
1.90 % Millennium Management LLC2,928,788912,35712/31/2023
1.43 % Opaleye Management Inc.2,215,000325,00012/31/2023
1
2
3
4
5
...
10

TG Therapeutics Executives and Management Board

Mr. Michael Weiss57
TG Therapeutics Chairman of the Board, President, Chief Executive Officer (since 2011)
Compensation 10.44 M
Mr. Sean Power41
TG Therapeutics Chief Financial Officer, Treasurer, Corporate Secretary
Compensation 1.97 M
Mr. Laurence Charney76
TG Therapeutics Lead Independent Director
Compensation 437,502
Mr. Kenneth Hoberman58
TG Therapeutics Independent Director
Compensation 397,502
Dr. Yann Echelard59
TG Therapeutics Independent Director
Compensation 395,002
1
2

TG Therapeutics stock: Frequently Asked Questions

What values and corporate philosophy does TG Therapeutics represent?

TG Therapeutics Inc represents a strong commitment to improving the lives of patients by developing innovative therapies in the field of hematological malignancies and autoimmune diseases. The company's corporate philosophy revolves around scientific excellence, patient-centricity, and collaborative partnerships. With a focus on research and development, TG Therapeutics Inc aims to bring transformative treatments to market that address unmet medical needs. Through its dedication to advancing medical science, this company strives to make a positive impact on the lives of patients, healthcare professionals, and the wider community.

In which countries and regions is TG Therapeutics primarily present?

TG Therapeutics Inc is primarily present in the United States. The company's headquarters are located in New York, and it focuses on the development and commercialization of novel treatments for various B-cell malignancies and autoimmune diseases. TG Therapeutics Inc primarily operates in the United States market, fostering collaborations with healthcare providers, research organizations, and regulatory authorities to advance its innovative therapies. With an unwavering commitment to improving patient outcomes, TG Therapeutics Inc continues to drive its presence and impact within the United States' healthcare landscape.

What significant milestones has the company TG Therapeutics achieved?

TG Therapeutics Inc, a leading biopharmaceutical company, has achieved several significant milestones. Most notably, the company received accelerated approval from the U.S. Food and Drug Administration (FDA) for its innovative therapy, umbralisib, in combination with ublituximab, for the treatment of adult patients with marginal zone lymphoma (MZL) and follicular lymphoma (FL). This approval marks a major breakthrough in the field of oncology and reinforces TG Therapeutics Inc's commitment to developing effective treatments for hematologic malignancies. Additionally, the company has successfully completed various clinical trials, demonstrating the potential of its pipeline to address unmet medical needs.

What is the history and background of the company TG Therapeutics?

TG Therapeutics Inc is a renowned biopharmaceutical company specializing in the development and commercialization of innovative therapies for the treatment of cancer and autoimmune diseases. Established in 1993, TG Therapeutics has emerged as a key player in the pharmaceutical industry, committed to advancing medical breakthroughs. With a focus on developing targeted therapies, the company has achieved significant milestones in its history. Over the years, TG Therapeutics has successfully introduced novel drugs and treatment options, catering to unmet medical needs. Their dedication to research and development, coupled with a strong commitment to patient care, has positioned TG Therapeutics Inc as a leading name in the healthcare sector.

Who are the main competitors of TG Therapeutics in the market?

The main competitors of TG Therapeutics Inc in the market include pharmaceutical companies such as AbbVie Inc., Roche Holding AG, and Johnson & Johnson. These companies operate in similar therapeutic areas and have a strong presence in the market. TG Therapeutics Inc faces competition in the development and commercialization of therapies for various conditions, such as lymphoma and chronic lymphocytic leukemia.

In which industries is TG Therapeutics primarily active?

TG Therapeutics Inc is primarily active in the biotechnology and healthcare industries.

What is the business model of TG Therapeutics?

The business model of TG Therapeutics Inc revolves around the development and commercialization of innovative biopharmaceutical products. Specializing in the field of oncology and B-cell malignancies, TG Therapeutics focuses on creating novel therapies to address the unmet medical needs of patients. By harnessing its expertise in research and development, the company aims to discover and develop targeted therapies that can improve the outcome and quality of life for individuals battling certain types of cancer. Through strategic partnerships, clinical trials, and regulatory initiatives, TG Therapeutics Inc strives to bring next-generation treatments to market, ultimately benefiting both patients and shareholders.

What is the P/E ratio of TG Therapeutics 2024?

The TG Therapeutics P/E ratio is -911.98.

What is the P/S ratio of TG Therapeutics 2024?

The TG Therapeutics P/S ratio is 8.56.

What is the AlleAktien quality score of TG Therapeutics?

The AlleAktien quality score for TG Therapeutics is 4/10.

What is the revenue of TG Therapeutics 2024?

The expected TG Therapeutics revenue is 314.9 M USD.

How high is the profit of TG Therapeutics 2024?

The expected TG Therapeutics profit is -2.96 M USD.

What is the business model of TG Therapeutics

TG Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of innovative therapies for cancer and autoimmune diseases. The company's business model includes the development of new drugs and their marketing. The company is divided into various divisions, each focused on specific therapy areas. These divisions include both cancer therapies and immunotherapies used in autoimmune diseases. Each division is led by highly qualified researchers specialized in researching specific types of cancer and autoimmune diseases and collaborate closely to discover advanced technologies. TG Therapeutics' flagship product is the BTK inhibitor Umbralisib, used in various cancers such as lymphomas or leukemias. This drug is a particularly potent molecule specifically developed for its effect on B lymphocytes. By inhibiting these cells, the division of cancer cells is inhibited, stopping the growth of tumor cells. The medication has great potential in treating cancer patients who do not respond to other therapies. In the field of immunotherapy, the company is developing products such as Ublituximab, used in the treatment of autoimmune diseases such as multiple sclerosis. This drug inhibits the activation of B cells, reducing excessive immune reactions in patients. This leads to a decrease in the number of relapses or symptoms of autoimmune diseases and slows down the progression of the disease. TG Therapeutics follows a business-to-business model, forming partnerships with other companies to market its products. However, the company also has extensive sales and marketing capabilities to sell its products directly to hospitals and medical facilities. There is a particular focus on multiple markets, especially in the USA, Europe, and Asia. The company generates revenue through product sales and partnerships with other biotech companies. These partnerships include research agreements and licensing agreements, where the company licenses its technologies and products to other firms for fees. Thus, TG Therapeutics generates income from various revenue streams and is able to continue its research and development and expand its business. In summary, TG Therapeutics' business model is focused on the development of innovative therapies for cancer and autoimmune diseases. Through the close collaboration between researchers and developers, the company has developed a range of therapies that can be used to treat various diseases. The company aims to market its products globally to maximize its success and increase its value for patients and investors.

What is the TG Therapeutics dividend?

TG Therapeutics pays a dividend of 0 USD distributed over payouts per year.

How often does TG Therapeutics pay dividends?

The dividend cannot currently be calculated for TG Therapeutics or the company does not pay out a dividend.

What is the TG Therapeutics ISIN?

The ISIN of TG Therapeutics is US88322Q1085.

What is the TG Therapeutics WKN?

The WKN of TG Therapeutics is A1JXW7.

What is the TG Therapeutics ticker?

The ticker of TG Therapeutics is TGTX.

How much dividend does TG Therapeutics pay?

Over the past 12 months, TG Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, TG Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of TG Therapeutics?

The current dividend yield of TG Therapeutics is .

When does TG Therapeutics pay dividends?

TG Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of TG Therapeutics?

TG Therapeutics paid dividends every year for the past 0 years.

What is the dividend of TG Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is TG Therapeutics located?

TG Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von TG Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TG Therapeutics from 7/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did TG Therapeutics pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of TG Therapeutics in the year 2023?

In the year 2023, TG Therapeutics distributed 0 USD as dividends.

In which currency does TG Therapeutics pay out the dividend?

The dividends of TG Therapeutics are distributed in USD.

Other fundamentals and analyses of TG Therapeutics in the deep dive.

Our stock analysis for TG Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TG Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

1. Introduction to the World of Stocks

The Fascination of Stock Markets

The world of the stock markets is fascinating and dynamic, a world where billions of euros change hands every day. For investors, stocks offer a unique opportunity to participate in the growth and success of companies. The simplest realization, perhaps: A stock is nothing more than a share in a company. This could be an investment in the local bakery, a coffee chain like Starbucks, or a software giant like Microsoft. Owning stocks means owning companies. All great and small fortunes are made through company ownership.

Eulerpool is a global financial data provider with offices in St. Gallen (Switzerland), Singapore, and Munich.

At Eulerpool Research Systems, we understand this fascination with stocks like the TG Therapeutics stock and offer private investors, asset managers, banks, and institutional investors access to comprehensive and reliable financial ratios, high-quality financial data, and intuitive analysis tools to make informed investment decisions.

What Are Stocks?

Shares represent stakes in a company, as is the case with the TG Therapeutics share. When you buy a share, you become a co-owner of that company. Stock trading takes place on exchanges, an organized market where buyers and sellers meet. The price of a share is determined by supply and demand and reflects the economic performance and potential of the company.

Significance of Stocks in Asset Accumulation

Investing in stocks means directly participating in economic growth. Compared to other forms of investment, stocks often offer higher returns, but they also carry higher risks. With the right tools and analyses, such as those provided by Eulerpool, investors can minimize these risks and make informed decisions.

Our companies create incredible value every day. Through great products and services that we all love. Whether it's coffee, Starbucks, real estate, software, or entertainment. Every product we use comes from a company. By owning shares, we participate in these businesses.

The Role of Stock Metrics and Analysis

The key to success in wealth accumulation with stocks lies in the thorough analysis and understanding of the underlying metrics. This is where Eulerpool Research Systems comes into play: We provide access to over a million securities and ten million metrics, offering our users a comprehensive analysis foundation. Private investors at Eulerpool have access to professional metrics and analysis tools on par with institutional investors.

Long-term Perspectives and Strategies with Stocks, ETFs, Funds, and Crypto

Successful investing requires a long-term perspective. It's not about taking advantage of short-term market fluctuations, but about identifying companies with solid fundamentals and growth potential. Eulerpool supports investors in recognizing such companies and sustainably building their portfolios.

Stocks are an essential component of the modern financial world. By deepening their understanding of stock markets and utilizing quality data and analyses, investors can successfully increase their wealth. Eulerpool Research Systems is by your side as a reliable partner on this journey.

2. Fundamentals of Stocks and ETFs with a Focus on TG Therapeutics

The Role of Stocks in the Financial Market

Stocks are fundamental building blocks of the financial market. A stock represents a share in a company, such as TG Therapeutics. It gives the holder a piece of the company and, depending on the type of stock, voting rights at the general meeting. Investors buy stocks in the hope that the company will grow, which is reflected in rising stock prices and potential dividend payouts.

ETFs: An Introduction

Exchange Traded Funds (ETFs) are investment funds that are traded on stock exchanges and replicate the composition of an index, such as the DAX or NASDAQ. They allow investors to invest in a broad portfolio of stocks like TG Therapeutics without having to buy each stock individually. ETFs are popular for their low fees and ease of handling.

TG Therapeutics in the world of stocks and ETFs

Companies like TG Therapeutics are often important components in many stock portfolios and ETFs. The valuation of TG Therapeutics therefore not only affects direct investors in the TG Therapeutics stock, but also investors who have invested in ETFs containing TG Therapeutics shares.

Dividends and TG Therapeutics

A key element for stock investors is the dividend that companies like TG Therapeutics distribute to their shareholders. The "dividend yield" of TG Therapeutics can be an important factor in determining whether a stock represents an attractive investment.

Analysis and Valuation of Stocks

Stock analysis and valuation is a crucial step in determining the true value of companies such as TG Therapeutics. This process involves analyzing various financial metrics and reports to gain a comprehensive picture of the financial health and potential of TG Therapeutics.

Both individual stocks and ETFs play an important role in an investor’s portfolio. Investing in companies like TG Therapeutics and understanding their role in ETFs are essential components for success in the world of finance. With the right tools and analyses, investors can make informed decisions about their investments in stocks and ETFs.

3. Stock Analysis: A Universal Guide

Fundamentals of Financial and Stock Analysis

Financial analysis is the backbone of every investment decision. Whether it involves stocks of technology companies, consumer goods manufacturers, or financial service providers, the analysis of financial metrics is crucial. It encompasses the evaluation of balance sheets, income statements, and cash flow statements.

Key Financial Ratios for Stocks

Core metrics include the price-to-earnings ratio (P/E), dividend yield, return on equity, and price-to-book ratio. The Eulerpool Fair Value is also becoming increasingly popular among professional investors. These metrics offer insights into the valuation, profitability, and financial health of a company.

Analysis of Corporate Performance

The analysis of company performance includes comparing historical data to identify trends in revenue, profit, and other key financial aspects. This analysis assists in forecasting future performance and assessing growth potential.

Eulerpool displays both historical data (up to 30 years of data history) on revenue, EBIT, profit, dividends, and many more, as well as professional forecasts for the coming 7 years.

Risk and Opportunity Assessment

The assessment of risks and opportunities is another important aspect of financial analysis. It encompasses the examination of market risks, credit risks, and operational risks, as well as the evaluation of opportunities arising from new market trends or technological innovations.

Long-Term Financial Outlook

The long-term financial perspective is particularly important for investors interested in sustainable growth and stable returns. This perspective takes into account long-term profitability, the ability to distribute dividends, and the potential for future growth.

A thorough stock analysis is crucial for the success of investments in stocks. Regardless of the industry or the specific company, a well-founded analysis allows investors to make informed decisions and achieve their investment goals.

4. Market and Industry Trends: Their Importance in Stock Analysis

Introduction to Market and Industry Trends

Market and industry trends play a crucial role in the valuation of stocks. Regardless of whether it involves companies from the technology, consumer goods, finance, or any other sector, knowledge of current and future trends is essential for investors.

Global Economic Trends

Analyzing global economic trends is fundamental to understanding the potential and risks of stock investments. These trends can be influenced by geopolitical changes, economic policies, technological advancements, and global events such as pandemics or economic crises.

Industry-Specific Developments

Every industry has its specific trends and challenges. Understanding these specific factors is crucial to assess a company's position within its industry and its potential compared to competitors.

Technological Innovations

Technological innovations can revolutionize entire industries and create new growth opportunities. A company's ability to adapt to and utilize technological changes is an important indicator of its future growth.

Sustainability and Social Responsibility

Sustainability and social responsibility are increasingly gaining importance. Companies that are leading in these areas may deliver better long-term performance, as they are better prepared for future regulatory changes and consumer preferences.

Market Dynamics and Competition

Analyzing market dynamics and competition is crucial to understand a company's strengths and weaknesses. This includes assessing market shares, competitive positioning, and strategic orientation.

Taking into account market and industry trends is an essential part of stock analysis. A deep understanding of these trends enables investors to make informed decisions and better assess the long-term prospects of an investment.

5. Investment Strategies: Diversification and Risk Management

Introduction to Investment Strategies Effective investment strategies are crucial for success in the stock market. Regardless of specific stocks or sectors, it is important to have a well-thought-out investment strategy that considers diversification and risk management.

Diversification: Key to Risk Management

Diversification is a fundamental strategy to minimize risk. It involves spreading investments across different asset classes, industries, and geographic regions to reduce the risk of market volatility and industry-specific downturns.

Long-Term vs. Short-Term Investment Strategies

Investors should distinguish between long-term and short-term investment strategies. Long-term strategies focus on holding stocks over extended periods to benefit from price increases and dividends. Short-term strategies, on the other hand, take advantage of current market trends and fluctuations.

Significance of Risk Tolerance

Individual risk tolerance plays a crucial role in choosing an investment strategy. It depends on various factors such as investment goals, time horizon, and personal comfort with volatility.

Fundamental Analysis and Technical Analysis

Both analysis methods are important for developing investment strategies. Fundamental analysis deals with the assessment of the intrinsic value of stocks, while technical analysis uses market movements and patterns to make trading decisions.

Portfolio Rebalancing

Regular rebalancing of the portfolio is important to maintain the desired risk profile. This includes adjusting the portfolio composition to ensure that it aligns with investment objectives and risk tolerance levels.

A well-thought-out investment strategy that considers diversification, risk tolerance, fundamental analysis, and technical analysis is essential for success in stock trading. Regular portfolio rebalancing helps manage risks and achieve investment goals.

6. Future Perspectives and Potentials in the Stock Market

Introduction to Future Market Trends The stock market is constantly subject to change, influenced by global economic trends, technological developments, and political decisions. Understanding this dynamic is essential for long-term oriented investors.

The Importance of Market Research and Forecasts

Market research and forecasts play a significant role in predicting future market trends. They help investors identify potential growth areas and industries with high potential.

The Influence of Technology and Innovation

Technological innovations are often drivers for market changes. New technologies can disrupt existing industries while simultaneously creating new investment opportunities. Investors should keep an eye on emerging technology trends and their potential impacts on various sectors.

Sustainability and ESG Investments

Sustainability and ESG criteria (Environmental, Social, Governance) are becoming increasingly important for investment decisions. Companies that are leading in these areas could demonstrate greater growth potential in the coming years.

Global Economic Changes

Global economic changes, such as demographic shifts, geopolitical movements, and economic policy decisions, influence stock markets worldwide. Understanding these factors is crucial for developing a robust investment strategy.

Risk Management and Future Vision

Effective risk management remains an important aspect for future investments. Investors should have a balanced vision that considers both potential risks and opportunities.

Taking into account future market trends and global economic changes is crucial for long-term success in the stock market. Investors should proactively monitor technology trends, sustainability, and geopolitical shifts to identify future investment opportunities and adjust their portfolio accordingly.

7. Case Studies: Successful Investment Strategies in the Stock Market

Introduction to Case Studies Analyzing case studies of successful investments offers valuable insights into effective strategies and decision-making processes in the stock market. These case studies can cover a wide range of industries and market conditions, making them relevant for investors of all types.

Analysis of Success Stories

By studying examples where investors have made significant gains, important lessons can be learned about market analysis, timing, and risk management. These stories offer not only inspiration but also practical lessons that can be directly applied to one's own investment strategies.

Understanding Errors and Failures

Equally instructive are case studies that deal with mistakes and failures. These examples help to identify common pitfalls in the stock market and understand how to avoid them in the future.

Diversification and Portfolio Strategy

Some case studies demonstrate how diversification and a well-thought-out portfolio strategy can lead to success. They underline the importance of risk distribution and the selection of stocks from different industries and regions.

Long-Term vs. Short-Term Strategies

Case studies provide insights into the differences between long-term and short-term investment strategies. They illustrate how different approaches can work in various market environments.

Adjustment to Market Changes

Another important aspect highlighted by case studies is the ability to adapt strategies to changing market conditions. Flexibility and adaptability are crucial factors for long-term success.

Case studies are an indispensable tool for learning and developing as an investor. They offer practical insights into successful strategies and help avoid mistakes. The analysis of case studies helps investors make informed and reflective investment decisions.

8. Practical Tips for Buying Stocks

Introduction to Stock Purchasing Purchasing stocks can be a rewarding decision for investors of all levels of experience. This chapter provides practical tips that will help you make smart and informed investment decisions.

Choosing the Right Broker

An important step in buying stocks is selecting a suitable broker. Key criteria for this are fee structures, user-friendliness of the platform, customer service, and the availability of research and analysis tools.

Understanding Market Mechanisms

Before you invest in stocks, it's important to understand the basics of the stock market, including how exchanges operate, buy and sell orders, and the significance of market capitalization and liquidity.

Conducting a thorough analysis

A careful analysis of the companies you wish to invest in is essential. This includes the evaluation of financial reports, analysis of industry trends, and consideration of corporate news and events.

Portfolio Diversification

Diversifying your portfolio across various industries and regions is a proven approach to minimizing risks and achieving stable returns in the long term.

Establishment of an Investment Strategy

Define your investment goals and risk tolerance and develop an investment strategy that suits your profile. Decide whether you want to pursue a long-term buy-and-hold strategy or a more active trading strategy.

Long-Term Perspective

Consider stock investments with a long-term perspective. Market fluctuations are normal, and taking a long-term view can help you avoid hasty decisions.

Continuous Education and Information

Stay informed about market and economic news, and continuously engage with the latest developments in the stock market. Education is a key aspect to succeed in stock trading.

Purchasing stocks requires careful consideration and a well-founded strategy. By selecting the right broker, thorough analysis, diversification, and a long-term perspective, you can maximize your chances of successful investments.

9. Summary and Outlook: The Path Forward in the Stock Market

Review of Key Points In this guide, we have covered various aspects of stock investing, from the basics of stocks and ETFs to financial analysis, market and industry trends, and practical tips for buying stocks. Each chapter aimed to provide investors with the necessary knowledge and tools to make informed decisions.

The Importance of Continuous Education

One of the most important insights is that the world of stock markets is dynamic and constantly changing. Therefore, continuous education and adjustment of investment strategies are crucial. Investors should always stay informed and regularly refresh their knowledge.

Adjustment to Market Changes

The ability to adapt to market changes is crucial for long-term success. Investors should remain flexible, recognize trends, and be willing to adjust their strategies accordingly.

Long-Term Perspectives

While short-term market volatility can pose a challenge, it is important to maintain a long-term perspective. Long-term investments have often proved to be an effective way to benefit from the market's growth potential.

Keep an Eye on Future Developments

Technological developments, global economic trends, and changes in corporate governance will continue to be important factors that influence the stock market. Investors should keep an eye on such developments and adjust their portfolios accordingly.

Final Thoughts

Investing in stocks offers many opportunities, but also requires diligence, research, and a thoughtful strategy. With the right tools, knowledge, and a proactive attitude, investors can fully leverage the potential of the stock market.

Outlook

The future of the stock market is full of opportunities. With sound strategies and an enlightened approach, investors can benefit from the chances the market offers.

10. Investment Psychology and Investor Behavior

Introduction to Investment Psychology Investment psychology is a critical, often overlooked aspect of the financial world. It examines how psychological factors influence the behavior of investors and, ultimately, the stock markets themselves.

Emotional Factors in the Investment Process

Investors are not purely rational actors and are often influenced by emotions such as greed and fear. These emotional responses can lead to irrational decisions, such as selling stocks in panic phases or excessive investments during boom phases.

Cognitive Biases and Their Effects

Cognitive biases such as confirmation bias (the tendency to search only for information that confirms one's own beliefs) and overconfidence (excessive self-confidence) can lead to flawed investment decisions. These biases can cause investors to underestimate risks and overvalue opportunities.

Herd Behavior in the Stock Market

Herd behavior refers to the phenomenon where investors tend to follow the crowd or market trends rather than trusting their own analysis and judgment. This can lead to market bubbles or exaggerated market corrections.

Strategies for Overcoming Emotional Decisions

Disciplined Investment Strategy: Develop a clear investment strategy and adhere to it to minimize emotional reactions. Diversification: Spread your investments across various asset classes to mitigate risk and reduce emotional reactions to market fluctuations. Long-Term Perspective: Focus on long-term objectives to withstand short-term market volatility. Importance of Education and Self-Reflection Education and awareness of one's biases and emotional tendencies are crucial. Regular self-reflection and studying investment psychology can help avoid typical pitfalls.

Investment psychology is an essential component of successful investment strategies. By understanding and considering psychological aspects, investors can make more disciplined, rational, and ultimately more successful investment decisions.

11. Technical Analysis in Detail

Introduction to Technical Analysis Technical analysis is a method for predicting future stock price movements based on the examination of past market data, primarily price and volume. It is founded on the assumption that market trends repeat themselves and that historical price movements are significant indicators of future activity.

Basic Principles of Technical Analysis

  • Market TrendsThe idea that markets follow trends that can be identified over various periods of time.
  • History repeats itselfThe assumption that market behavior and patterns will repeat over time.
  • Prices reflect everythingThe belief that all current market prices reflect all available information. Chart patterns and what they mean.
  • Head and shoulders patternA reversible pattern that typically occurs at the end of an uptrend.
  • Double Top and Double BottomPatterns that indicate peaks or valleys in the price history and often signal a trend reversal.
  • Triangles and FlagsContinuation patterns indicating a continuation of the current trend. Technical indicators and their application.
  • Moving Averages (gleitende Durchschnitte)Smoothing of price fluctuations over a specific period.
  • Relative Strength Index (RSI)A momentum indicator that signals overbought or oversold conditions.
  • MACD (Moving Average Convergence Divergence)A trend-following momentum indicator. Volume Analysis: Trading volume plays a crucial role in technical analysis, as it can provide additional insight into the strength of an existing trend.

Candlestick Analysis

Candlestick charts provide detailed information about market sentiment and can help identify turning points in the market.

Risks and Limitations of Technical Analysis

While technical analysis can provide valuable insights, it is not without faults. Incorrect signals and self-fulfilling predictions are potential risks.

Technical analysis is a powerful tool in the arsenal of any investor. It provides insights into market trends and sentiments which, when interpreted correctly, can lead to informed trading decisions. However, it should always be used in combination with other forms of analysis and within the context of the overall market.

12. Fundamental Analysis in Detail

Introduction to Fundamental Analysis Fundamental analysis is a method of evaluating the intrinsic value of a stock, based on economic, financial, and other qualitative and quantitative factors. It aims to understand the underlying health and performance of a company.

Core Aspects of Fundamental Analysis

  • Financial ReportsAnalysis of balance sheets, income statements, and cash flow statements to assess the financial health of a company.
  • Industry AnalysisExamination of industry dynamics, market size, growth potential, and competitive landscape.
  • Corporate GovernanceAssessment of Management Quality and Corporate Governance. Evaluation Metrics.
  • Price-Earnings Ratio (P/E)Measures the price of a stock in relation to its earnings.
  • Price-Book Value Ratio (P/B Ratio)Compares the market value with the book value of a company.
  • Dividend YieldThe percentage of the company's profit that is distributed as a dividend to shareholders.

Analysis of Earning Power

The ability of a company to generate and increase profits is a central aspect of fundamental analysis. This includes evaluating revenue growth rates, profit margins, and cash flow generation.

Long-Term Perspectives and Sustainability

Fundamental analysis also includes the assessment of a company's long-term prospects and its ability to generate sustainable growth.

Macroeconomic Factors

Consideration of macroeconomic factors such as interest rates, inflation rates, and economic cycles that can affect the overall economy and specific industries.

Risks and Limitations of Fundamental Analysis

Fundamental analysis can be time-consuming and may not take into account short-term market fluctuations. Additionally, data interpretation can be subjective.

Fundamental analysis is an essential tool for long-term oriented investors. It helps to determine the true value of a stock and make informed investment decisions based on the financial and economic performance of a company.

13. Macroeconomic Factors and the Stock Market

Introduction to Macroeconomic Factors Macroeconomic factors play a crucial role in shaping global financial markets. This chapter examines how economic policy, interest rates, inflation, and other macroeconomic indicators influence the stock market.

The world of finance is complex and multifaceted, and one of the key factors that both new and experienced investors should always keep an eye on are the macroeconomic factors. These global economic indicators often have a profound impact on the stock markets. In this blog post, we illuminate how central banks, economic growth, inflation, and global trade dynamics shape the stock markets.

The Role of Central Banks

Monetary policy decisions by central banks, such as setting interest rates, have immediate effects on the stock markets. Low interest rates can boost the stock markets as they create more favorable credit conditions for companies and consumers, thereby promoting economic growth. On the other hand, rising interest rates can put pressure on the markets as they increase borrowing costs and can slow down growth.

Economic Growth and Labor Market

Gross Domestic Product (GDP) is an important indicator of overall economic health. Strong economic growth often signals good conditions for stock investments, as it usually comes with higher corporate profits and stronger consumer demand. Similarly, robust labor market conditions, reflected in low unemployment rates and strong wage growth, are typically positive for the stock markets.

Inflation – A Double-Edged Sword

Inflation can erode purchasing power, but it can also be a sign of a growing economy. Moderate inflation is often seen as healthy, but high inflation can lead to uncertainty and prompt central banks to raise interest rates, which can negatively affect the stock markets.

Global Trading Dynamics

International trade relations and conflicts, such as tariffs and trade wars, can have significant impacts on stock markets. Companies heavily involved in international trade can be particularly vulnerable to such geopolitical tensions.

Conclusion

Macroeconomic factors provide important insights into the general market direction and should be carefully observed by every investor. A comprehensive understanding of these factors allows investors to make informed decisions and adjust their portfolios accordingly to safeguard against potential risks and capitalize on opportunities.

Macroeconomic factors are an integral part of the analysis of stock markets. A comprehensive understanding of these factors enables investors to make better decisions by considering the broader economic conditions that can influence market performance.

14. Investing in Different Market Phases

Introduction to Market Cycles

The stock market goes through various phases influenced by different economic, political, and psychological factors. This chapter examines strategies for investing in different market phases: bull markets, bear markets, and correction periods.

The stock market is known for its cycles of ups and downs. For investors, understanding these market phases—bull markets, bear markets, and correction phases—can be the key to success. In this post, we examine effective strategies for each of these market phases.

Bull Market Strategies

CharacteristicsA bull market is characterized by rising stock prices, a strong economy, and positive investor sentiment.

Investment StrategiesIn a bull market, investors should focus their portfolio on growth stocks. Companies with high potential and innovative business models can particularly benefit in this phase.

Risk ManagementEven when sentiment is positive, investors should keep a potential overvaluation in mind and diversify to minimize risks.

Bear Market Strategies

FeaturesBear markets are characterized by falling prices and a pessimistic mood among investors.

Investment StrategiesThis is the time to look for undervalued, high-quality stocks. Defensive stocks that generate stable returns can be a safe investment in bear markets.

Long-term PerspectiveBear markets can be frightening, but they also offer buying opportunities for long-term oriented investors.

Strategies for Market Volatility and Corrections

Dealing with FluctuationsMarket volatility can offer short-term buying and selling opportunities, but requires good timing and an understanding of market trends.

Opportunities in CorrectionsA market correction phase in which prices fall by 10% or more can be an opportunity to acquire high-quality stocks at lower prices.

Psychological AspectsInvesting is not just a matter of numbers, but also of psychology. Discipline and avoiding emotional decisions are essential in all market phases.

Whether in a bull or bear market, the key principle is to stay informed and adapt to changing conditions. By understanding the different market phases and applying appropriate strategies, investors can maximize their success regardless of the prevailing market conditions.

Every market phase presents unique challenges and opportunities. By understanding the characteristics of each phase and applying appropriate strategies, investors can improve their chances of success across different market cycles.

15. Taxation Aspects of Stock Trading

Introduction to Tax Aspects

Trading stocks not only affects the return but also the investor's tax burden. This chapter covers basic tax aspects to consider when buying and selling stocks.

Investing in stocks can be a rewarding way to grow your wealth. But are you also considering the tax implications of your investment decisions? In this blog post, we take a detailed look at the tax aspects of stock trading and offer valuable tips on how to minimize your tax burden.

1. Understanding the Taxation of Capital Gains

Whether you receive dividends or sell shares at a profit, your capital gains are taxable. It's important to understand how these incomes are taxed in your country and what allowances you may be eligible for.

2. The Art of Loss Offset

Not every stock trade ends profitably. However, the tax office allows you to offset losses against gains. Learn about the loss offsetting rules and how you can carry forward losses to reduce your future tax burden.

3. Utilize Allowances and Tax Exemptions

In many countries, there are tax allowances for capital gains. Inform yourself about your local laws to ensure that you are making use of all available tax benefits.

4. International Taxation – Avoiding Double Taxation

Are you investing in foreign stocks? Then you should familiarize yourself with withholding tax and the rules for avoiding double taxation. Double taxation agreements between countries can play a role in this.

5. Tax Planning is Crucial

Long-term tax planning can help you optimize your tax burden. Consider the holding periods of stocks and plan your sales strategically.

Tax planning is an integral part of successful stock trading. By having a basic understanding of the tax aspects, you can ensure that you do not pay more taxes than necessary and maximize your returns. Remember to consult a tax advisor or financial expert if needed to get individual advice for your specific situation.

Considering tax aspects is an important part of stock trading. Effective tax planning can significantly impact the net return of stock investments. Investors should be aware of the tax implications of their investment decisions and seek professional advice if necessary.

16. Ethical and Sustainable Investing

Ethical investing, often also referred to as socially responsible investing (SRI) or sustainable investing, focuses on generating financial returns while concurrently promoting positive social and environmental impacts.

In a time when sustainability and social responsibility are becoming increasingly focused on, ethical investing is also gaining in importance. Ethical investing, often referred to as socially responsible investing (SRI) or ESG investing (Environmental, Social, Governance), enables investors to not only achieve financial returns but also promote positive changes in society and the environment.

What is Ethical Investing?

Ethical investing is the practice of investing capital in companies and funds that have positive social and environmental impacts. This approach takes into account ethical, social, and ecological criteria in selecting investments to ensure that the invested money aligns with the investor’s personal values.

The Three Pillars of ESG Investing

Environment (Environmental)

Investments in companies that promote environmentally friendly practices, such as renewable energy and sustainable resource use.

Social

Supporting companies that provide fair working conditions and actively contribute to the community.

Corporate Governance

Focus on companies with ethical leadership practices, including transparency and accountability. Why Invest Ethically?

Ethical investing offers not only the opportunity to invest in one's own financial future but also to contribute to a more sustainable and just world. It allows investors to support companies that have a positive social and environmental impact, while simultaneously avoiding firms that contradict their values.

Challenges and Opportunities

Although ethical investing offers many advantages, there are also challenges. These include assessing ESG criteria and determining the real social and ecological impact of investments. Nevertheless, this approach presents opportunities for long-term growth and the chance to be part of a larger movement for positive change.

Ethical investing is more than just an investment strategy; it's an expression of personal values and beliefs. In a world where we are increasingly seeking ways to effect positive change, it offers a powerful means to deploy our capital for good.

17. The Influence of Central Banks and Monetary Policy on the Stock Market

In the world of finance, central banks play a leading role. Their monetary policy decisions have far-reaching effects, not only on the economy in general but also specifically on the stock markets. In this blog post, we illuminate how the actions of central banks, especially the setting of key interest rates and quantitative easing, can influence the stock markets.

Central Banks as Market Regulators

Central banks, such as the European Central Bank (ECB) or the US Federal Reserve (Fed), are tasked with stabilizing the economy. By adjusting key interest rates and open market operations, they control the money supply and thus influence inflation and economic growth.

Interest Rates and Their Impact on Stocks

One of the most powerful tools of central banks is the key interest rates. Low interest rates reduce the cost of loans, which benefits companies and consumers. This can lead to increased corporate profits and thus raise stock prices. Conversely, high interest rates can increase borrowing costs, which can negatively affect corporate profits and thereby stock prices.

Quantitative Easing – A Double-Edged Sword

Quantitative easing (QE) is another measure employed during times of economic distress. By purchasing securities, the central bank increases the money supply and thereby stimulates economic activity. This can lead to a higher valuation of stocks as investors seek out higher-yielding investments. However, this policy carries the risk of inflation and market distortions.

The Role of Expectations

Not only the actual measures of central banks play a significant role, but the expectations of investors are also important. Announcements and forecasts can lead to immediate market reactions, even if the measures themselves are implemented later.

Globally interconnected financial markets

In our globalized world, the actions of a major central bank cannot be considered in isolation. Coordinated or countervailing monetary policies in different countries can have complex effects on international stock markets.

Central bank monetary policy is a key factor in the stock market. Investors should always keep an eye on the decisions and announcements of central banks to adjust their investment strategies accordingly. A solid understanding of monetary policy can help to better understand the dynamics of the stock markets and make smart investment decisions.

Appendix: Eulerpool Glossary and Additional Resources

Glossary of Key Terms

Throughout this guide, numerous technical terms have been used. Below you will find a glossary of the most important terms to enhance your to deepen understanding:

  • ShareA financial instrument that represents ownership interests in a company.
  • ETF (Exchange-Traded Fund)An exchange-traded fund that replicates the composition of an index.
  • P/E Ratio (Price-Earnings Ratio)A metric that represents the share price of a company in relation to its earnings per share.
  • Dividend YieldThe percentage that indicates the ratio of the dividend to the current share price.
  • Market CapitalizationThe total value of a company's outstanding shares.
  • LiquidityThe ability of an asset to be quickly converted into cash without a significant loss in value.
  • Risk toleranceThe degree of uncertainty in investment performance that an investor is willing to accept.

Further Resources

For those who want to further deepen their knowledge, here are some recommended resources listed:

  • Financial news websitesWebsites such as Bloomberg, Reuters, and Financial Times provide current information and analysis.
  • Educational ResourcesOnline platforms such as Investopedia, Khan Academy, and Coursera offer courses and materials for financial education.
  • Specialist booksThere are a multitude of books on stock investing, ranging from beginner's guides to advanced manuals.
  • Podcasts and WebinarsMany experts and market observers share their knowledge in podcasts and webinars, which offer a convenient way to stay up-to-date.

Closing Remarks

This appendix serves as a useful reference and starting point for further studies. The world of stock investments is extensive and constantly changing, thus it is important to continuously educate oneself and stay informed.